Everolimus for preventing organ rejection in liver transplantation

  • Technology appraisal guidance
  • TA348
  • Published: 
Download guidance (PDF)

1 Guidance

1.1 Everolimus is not recommended within its marketing authorisation for preventing organ rejection in people having a liver transplant.

1.2 People whose treatment with everolimus was started within the NHS before this guidance was published, should be able to continue everolimus until they and their NHS clinician consider it appropriate to stop.